PharmaCyte Biotech, Inc. Common Stock
Symbol: PMCB (NASDAQ)
1.05
▲ (0.48%) 0.005
Company Description:
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
Key Stats
- Today's Open: $1.04
- Today's High: $1.1
- Today's Low: $1.045
- Today's Volume: 15.43K
- Yesterday Close: $1.04
- Yesterday High: $1.0699
- Yesterday Low: $1.03
- Yesterday Volume: 76.17K
- Last Min Volume: 6
- Last Min High: $1.045
- Last Min Low: $1.045
- Last Min VWAP: $1.045
Company Profile
- Name: PharmaCyte Biotech, Inc. Common Stock
- Website: https://pharmacyte.com
- Listed Date: 2003-09-11
- Location: LAS VEGAS, NV
- Market Status: Active
- CIK Number: 0001157075
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $7.07M
- Round Lot: 100
- Outstanding Shares: 6.80M
- Asset Type: CS
RECENT FILINGS FOR PMCB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 8-K | View |
| 2025-09-04 | D | View |
| 2025-08-18 | 8-K | View |
| 2025-08-11 | 10-K | View |
| 2025-07-29 | NT 10-K | View |
| 2025-04-24 | 8-K | View |
| 2025-03-17 | 10-Q | View |
| 2025-03-10 | ARS | View |
| 2025-03-10 | DEFA14A | View |
| 2025-03-10 | DEF 14A | View |
| 2025-02-26 | 8-K | View |
| 2025-02-13 | SCHEDULE 13G/A | View |
| 2025-01-15 | SCHEDULE 13G/A | View |
| 2024-12-13 | 10-Q | View |
| 2024-12-04 | S-8 | View |
| 2024-11-13 | SC 13G/A | View |
| 2024-09-17 | 10-Q | View |
| 2024-09-17 | NT 10-Q | View |
| 2024-08-13 | 10-K | View |
| 2024-07-29 | NT 10-K | View |